- Coordinator
- Uniwersytet Jagiellonski, Poland
- Runs
- 1 January 2027 to 31 December 2029
- Status
- Running
- EU funding
- €1.5m
- Total cost
- —
- Partners
- 5 organisations in 5 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101339361
What the project is doing
In the project's own words, from its summary on CORDIS.
This project establishes an integrated capacity-building framework for analysing drug-induced changes in cellular organisation by combining quantitative proteomics, post-translational modification (PTM) profiling, single-cell analysis and in situ structural biology. Its main objective is to institutionalise at the Małopolska Centre of Biotechnology (MCB) a coherent and reproducible workflow that links biochemical measurements with spatial and structural interpretation, addressing the current fragmentation of expertise.
Drug exposure is used as a controlled and transferable perturbation model relevant to metabolic and civilisation-related diseases. Rather than focusing on drug discovery, the project emphasises methodological training and mechanistic understanding of how chemical perturbations reshape protein abundance, PTM states, molecular interactions and cellular architecture, providing a robust testbed for integrated, multiscale analysis.
Through collaboration with leading European partners, the project enables structured transfer of expertise in advanced proteomics, PTM-centric analysis, single-cell methodologies, visual proteomics, cellular cryo-electron tomography, high-resolution structural biology and computational modelling. Knowledge transfer is embedded through joint measurement campaigns, staff exchanges, hands-on training and shared benchmarking.
A key enabling component is the establishment and professionalisation of a Grant Office at MCB. By strengthening administrative competences and creating a durable interface between researchers and research support, the project enhances MCB’s ability to participate in competitive European funding schemes and supports long-term integration into the European Research Area. By the end of the project, MCB will operate an integrated, PTM-aware and structure-resolved analytical platform supported by a strengthened institutional support environment.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Uniwersytet Jagiellonski | Krakow | Poland | Coordinator |
| European Molecular Biology Laboratory | Heidelberg | Germany | Participant |
| Syddansk Universitet | Odense M | Denmark | Participant |
| Fundacion Para La Formacion E Investigacion Sanitarias De La Region De Murcia | Murcia | Spain | Participant |
| Lunds Universitet | Lund | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI